Insulin sensitivity (IS) is the ability of cells to react due to insulin´s presence; when this ability is diminished, low insulin sensitivity or insulin resistance (IR) is considered. IR had been related to other metabolic disorders as metabolic syndrome (MS), obesity, dyslipidemia and diabetes. IS can be determined using direct or indirect methods. The indirect methods are less accurate and invasive than direct and they use glucose and insulin values from oral glucose tolerance test (OGTT). The accuracy is established by comparison using spearman rank correlation coefficient between direct and indirect method. This paper aims to propose a lipid-anthropometric index which offers acceptable correlation to insulin sensitivity index for different populations (DB1=MS subjects, DB2=sedentary without MS subjects and DB3=marathoners subjects) without to use OGTT glucose and insulin values. The proposed method is parametrically optimized through a random cross-validation, using the spearman rank correlation as comparator with CAUMO method. CAUMO is an indirect method designed from a simplification of the minimal model intravenous glucose tolerance test direct method (MINMOD-IGTT) and with acceptable correlation (0.89). The results show that the proposed optimized method got a better correlation with CAUMO in all populations compared to non-optimized. On the other hand, it was observed that the optimized method has better correlation with CAUMO in DB2 and DB3 groups than HOMA-IR method, which is the most widely used for diagnosing insulin resistance. The optimized propose method could detect incipient insulin resistance, when classify as insulin resistant subjects that present impaired postprandial insulin and glucose values.
INTRODUCTION
The normal blood concentration values of glucose are ranked between 60-100 mg/dl, and they are regulated by pancreas through β and α cells. They produce insulin and glucagon respectively. Insulin´s function is to transport the glucose through cell membrane into the cell, diminishing glucose levels in plasma. Glucagon, in the other side, allows glucose´s release into plasma, increasing glucose levels in plasma. When this balance is compromised by genetic or environmental causes, several metabolic disorders can appear; among them: insulin low sensitivity or insulin resistance (IR) [1] .
Insulin sensitivity is the ability of cells to react due to insulin´s presence [1] . When cell shows incapacity to capture glucose on plasmatic insulin´s presence, low insulin sensitivity or insulin resistance is considered. This metabolic dysfunction brings the appearance of disorders like metabolic syndrome, obesity, cardiovascular pathologies and eventually diabetes [2] .
Insulin sensitivity can be quantified using both direct and indirect methods. The direct ones like EuglycemicHyperinsulinemic Clamp and Minimal Model for Intravenous Glucose Tolerance Test (MINMOD-IGTT) are very accurate, but they use risky and expensive protocols. Indirect methods like HOMA-IR and CAUMO are less accurate but easier and safer because they use glucose and insulin values from oral glucose tolerance test (OGTT) for insulin sensitivity´s quantification. Spearman Correlation technique is used to establish indirect methods´ accuracy through direct method. The most correlated are the results between both indirect and direct methods; more accurate is the indirect one. There are many indirect methods for insulin sensitivity quantification; HOMA-IR is the most used in clinical practice for IR diagnosis. HOMA-IR uses fasting insulin and glucose values to calculate insulin sensitivity and the cut value (considered normal) is for HOMA-IR<2.5 [3] , nonetheless it´s accuracy is not the best (Spearman with MINMOD-IGTT = 0.67) [4] , if compared with another indirect methods like CAUMO. CAUMO comes from a MINMOD-IGTT simplification, is a precise method (Spearman with MINMOD-IGTT = 0.89) which utilizes insulin and glucose values from OGTT [5] .
OGTT is a widely applied protocol in both epidemiological and research studies. It consists in (i) one measure of insulin and glucose levels in fasting conditions (0 minutes), (ii) followed by four more samplings after 75 ml glucose intake at 30 minute interval between measures (30, 60, 90 and 120 minutes or postprandial). The entire test last for 2 hours. Even if the OGTT is less invasive than direct methods, it is still an invasive and expensive test.
Low insulin sensitivity is related to a wide waist circumference (WC) [6] , Dyslipidemia, predisposition to have cardiovascular diseases, atherosclerosis and obesity. WC is a simple yet valuable anthropometric measure of abdominal fat. American Hearth & Lung Institute recommends WC for establish overweight and obesity [7] . WC is related to Body Mass Index (BMI), but varied correlation levels suggest that these measures could provide different information, thus not interchangeable. Practical considerations suggest the use of WC as alternative for BMI [8] . Nowadays the BMI is the most utilized index because of its good correlation to adiposity and strong epidemiological association to mortality and morbidity associated to obesity. Introduced in 1972, by Ancel Keys [9] , the BMI is set by divide the body weight (in kilograms) into the square of the height (in meters). The classification values of BMI to define low weight, normal weight, overweight and obesity and cut points, were proposed by World Health Organization (WHO) in 1998 [10] .
The aim of the study is to propose a lipid-anthropometric index (LAI) which offers good correlation to insulin sensitivity index for different populations without to use the glucose and insulin values from OGTT. The index design will be made by using correspondence analysis and linear regressions. Later a parametric optimization of the index (LAI-OPT) will be performed, according to the data obtained from professional marathon runners, metabolic syndrome and sedentary non metabolic syndrome subjects, taking as target function CAUMO´s method. The method of CAUMO has been retained as the gold standard due to the difficulty of applying any direct method. CAUMO is also an indirect method, but since it was derived from MINMOD-IGTT [5] , it has a good correlation coefficient with this direct method. The correlation between the proposed index and CAUMO will be performed using the spearman´s rank correlation coefficient. The parametric optimization will be based on previous study [11] but it will be applying a random cross validation.
In the next section data base characteristics will be explained, as well as methodological procedure and statistical analysis performed. In section three, results will be presented. Section four will show the discussions about results, and finally in section five conclusions and future works proposals will be presented.
METHODOLOGY

Data Base
The data base used in this investigation is composed from 40 male subjects discretized in three types of populations: sedentaries with metabolic syndrome (DB1), sedentaries without metabolic syndrome (DB2) and full time dedicated marathonists (DB3) with a weekly 180 to 240 training routine. The characteristics of these populations are:
• DB1: 15 subjects, BMI=34±7 kg/m2, age 31±7 years old, triglycerides=223,800±89,236 mg/dL, VLDL= 37,545±18,381 mg/dL, WC=113,633±19,351 cm. 9/15 subjects show IR (HOMAIR>2.5).
• DB2: 10 subjects BMI = 23±4 kg/m2, age 27±4 years old, triglycerides=100,400±66,555mg/dL, VLDL= 19,900±13,412 mg/dL, WC =83,510±10,754 cm. All subjects show normal insulin sensitivity (HOMA-IR<2.5).
• DB3: 15 subjects BMI =21±2 Kg/m2, age 33±9 years old, triglycerides=61,067±21,963 mg/dL, VLDL=12,213±4,393 mg/dL, WC =73,067±5,066 cm. All subjects show normal insulin sensitivity (HOMA-IR<2.5).
To each subject was performed an hematology, a lipid profile, and a five points OGTT (fasting glucose and insulin measures and four samples taken in a 30 minute interval after the 75 ml glucose intake). Clinical protocol lasts 120 minutes per subject [12] [13] . The clinical protocol adhered to the principles of the Declaration of Helsinki and was approved by the Ethical Committee of the University Hospital of Caracas; all the subjects gave a written informed consent.
Methodological procedure
The procedure used to design the proposed lipid-anthropometric index configuration was performed in two phases (figure 1). In the first one, biochemical and anthropometric variables and its relations among different groups were analyzed using Simple Correspondence Analysis (SCA). The correspondent relations between insulin and BMI, insulin and WC were corroborated; likewise the correspondence between glucose and BMI, glucose and WC, were established due to Linear Regression method. Finally in phase two, the proposed index was optimized using the random subsampling cross validation for each group with CAUMO as target function. 
Study of anthropometrical and biochemical variables
In phase one a SCA was performed. SCA is a descriptive technique which allows a simultaneous representation of variables and individuals in the same space; it builds a map and characterizes the main variables resulting from different profiles. Graphical representation eases perception and interpretation of data into a two-dimensional space, where axis or factors represents percentage of the variables [14] . In SCA performed for this study, numerical variables were defined by biochemical and anthropometrical measurements taken from each individual. On the other hand, categorical variable represents the amount of individuals belonging to each category. Finally, individuals are the subjects belonging to each population.
Once multifactor analysis was performed, scatter plots was made between glucose vs. WC, glucose vs. BMI, insulin vs. WC and insulin vs. BMI; for each value of glucose and insulin of OGTT, in order to assess if correlations were direct or inversely proportional. 
STEP 3
Validation data
It is repeated 10 times
The average of the α, β and γ, obtained in STEP 3, are taken as final parameters Search the combination of the parameters α, β, γ; with the best correlation with CAUMO method
The optimized parameters (α, β, γ) training in STEP 2, are used to find the correlation with the CAUMO method Uniform distribution
STEP 1
Random selection for validation and training data
Proposed method optimization using repeated random sub-sampling validation
Random sub-sampling validation method randomly separates data in: training data and validation data. In each separation, classifier algorithm is re-trained with correspondent data and validated with remaining data. Results are later averaged [15] . In figure 2 a scheme of parametrical optimization of proposed index can be observed. In step one, a random selection of training and validation data is made using a uniform distribution (70% of data was taken for training and remaining data for validation in each populations). In step two, training sample is used to change new index´s parameters until find a proper combination where the Spearman correlation of the new index with CAUMO as target function be the best. In step three, validation samples and parameters found in step two are used in order to obtain the Spearman Correlation of proposed index optimized with CAUMO; steps one to three are performed ten times. Finally, parameters which had given the best correlation on step three will be averaged to obtain final parameters.
CAUMO [5] 
RESULTS
Study of anthropometrical and biochemical variables
The relations between the different groups and variables (anthropometric and lipids) are show in SCA ( figure 3 ). The categorical variables was defined as normal or impaired; taking as cut value the ones established in literature [16] , values are reported in table 1. In figure 3b subject distribution according to population types are shown. Most contributive variables for axis 2 are VLDL (22.98%) and triglycerides (26.32%). These variables discriminate among the subjects from DB3, DB2 and DB1 groups. These two variables are shown in figure 3a which normal triglycerides (NT) and impaired triglycerides (IT) are related to DB3 and DB1 populations respectively. Same associations can be observed in obese (OB) and normal weight (NW), which were classified by BMI, OB subjects are related to DB1 population and NW are related to DB3 subjects. Scatter plots were performed between glucose and insulin values from OGTT and variables (WC, BMI and triglycerides). Figure 4 show the scatter plots between fasting insulin and glucose vs. WC, fasting insulin and glucose vs. BMI and fasting insulin and glucose vs. triglycerides, scatter plots between variables and other values of glucose and insulin from OGTT were also determined but are not shown due to space limitations. In figure 4 , it can be observe a strong linear correlation and direct proportionality between WC and BMI with fasting insulin, and a weak linear correlation between triglycerides and fasting insulin, (BMI: Pearson Correlation r= 0.668; WC: r=0.709; triglycerides: r=0.393) additionally, a weak linear correlation and direct proportionality between variables and fasting glucose (BMI: r=0.316; WC: r=0.332; triglycerides r= 0.296). The direct proportionality between WC, BMI, and triglycerides with the values of glucose and insulin (which are the main parameters to measure insulin sensitivity), is the reason that justifies the position of those variables as multiplier factors into the index.
Random sub-sampling cross validation optimization for the proposed index
Based on biochemical and anthropometric variable study results, the weight, height, WC and triglycerides were the selected variables for the construction of the new LAI (equation 2). These four parameters were selected for two reasons: (i) in the SCA, the impaired values of WC, BMI and triglycerides show to be related to DB1, which it is the group with lower insulin sensitivity; and (ii) they keep a direct proportionality with insulin and glucose values, which are the main parameters for insulin sensitivity characterization.
In equation 2 is presented the LAI. Where: BMI is the body mass index defined as body weight per the square of height (kg/m 2 ), WC is the abdominal circumference (m), it is in square form in order to provide more weight due to the fact this the most correlated parameter to insulin and glucose (see figure 4) , TG is the plasmatic triglycerides value and TG N = 150 mg/dL is the cut value considered as normal triglycerides value by literature [13] .
For LAI optimization (see equation 3) is proposed the addition of three parameters to each variable (BMI + α, WC
2 + β and TG/TG N + γ). The values of parameters were modified until the best Spearman's rank correlation coefficient (r close to ±1) between optimized index (LAI-OPT) and the method of CAUMO was obtained (see methodology).
On figure 5 are presented the box plots of insulin sensitivity assessment on each population using CAUMO (5a), HOMA-IR (5b), LAI-OPT (5c) and LAI (5d). Since HOMA-IR, LAI-OPT and LAI have an inversely proportional relation with CAUMO the interpretation of these indexes is different from CAUMO. With CAUMO higher value means higher insulin sensitivity, otherwise, with HOMA-IR, LAI-OPT and LAI, it is the opposite. In CAUMO, HOMA-IR, LAO-OPT and LAI, DB3 subjects have statistically higher insulin sensitivity than DB1 (p-value ANOVA HOMA-IR=0.001; CAUMO=0.0001; LAI-OPT=0.000003; LAI= 0.000003), and DB2 subjects have statistically higher insulin sensitivity than DB1 (p value HOMA-IR=0.001; CAUMO=0.0001; LAI-OPT=0.003; LAI= 0.0001). Only in LAI-OPT and LAI, DB3 subjects have statistically higher insulin sensitivity than DB2 (p value LAI-OPT=0.00003; LAI= 0.008). On table 3, α, β and γ values mean and standard deviation of each group optimization are shown (see methodology). Also it can be seen negative values of α, β and γ showed better correlation. Because of this fact, proposed index is build with a minus sign to avoid work with negative values.
In figure 6 is presented the scatter plot of normalized values from LAI and LAI-OPT. For normalization, each index value is divided by the maximum value. In LAI-OPT, low insulin sensitivity subjects are classified into the first quadrant plus two more subjects who show altered WC, triglycerides, postprandial glucose and insulin values. These subjects are not classified by HOMA-IR as insulin resistant subjects because they don´t present altered fasting glucose and insulin values. Regarding LAI, is shown that low insulin sensitivity subjects are classified on the upper quadrant. On this same quadrant two DB2 and four DB1 who doesn´t show insulin resistance are shown. 
DISCUSSION
Simple correspondence analysis shows that impaired WC, triglycerides and BMI are related to metabolic alterations diseases as metabolic syndrome and IR. On figure 3a, normal triglycerides (NT), normal weight (PN) and normal WC are linked to DB3 and DB2; otherwise, impaired triglycerides (IT), obese subjects (OB) and impaired WC are linked to DB1 population. According to distribution shown on figure 3b, triglycerides and VLDL, which are the most contributive variables in axis 2 (VLDL with less contribution), can discriminate among normal subjects (DB2 and DB3) and metabolic syndrome subjects (DB1). All these facts are the reasons of WC, BMI and triglycerides were chosen as parameters for the proposed index.
For new index conformation, the nature of relations between variables (WC, triglycerides and BMI) and glucose-insulin during OGTT was studied. Scatter plots show triglycerides, WC and BMI have direct proportionality relation with glucose and insulin values among all studied groups (see figure 4 ). For this reason the variables were placed as multiplier factors in the index. The regressions showed that insulin is the best correlated variable to BMI and WC, followed by triglycerides and finally by glucose which seemed to have a direct proportionality but not linear. These suggest the possibility of relate anthropometric and lipid measures, to insulin-glucose values.
The optimization performed to the proposed index, improves its correlation to CAUMO, as shown on table 2 where the Spearman correlations for LAI-OPT are better among all populations than LAI. On the other hand, LAI-OPT is better correlated to CAUMO than HOMA-IR, among DB2 and DB3 subjects; suggesting that LAI-OPT is a better insulin sensitivity estimator than HOMA-IR among those populations.
Optimized index could estimate insulin sensitivity in early stages. Optimization performed at LAI, improves its discriminating capabilities among insulin resistance subjects; on figure 6, optimized index distributes insulin resistance subjects at the right quadrant; into that group, two subjects with impaired WC, triglycerides and postprandial insulinglucose, are shown. This is very important because even if these subjects were not classified by HOMA-IR as insulin resistant, they have fasting insulin-glucose altered values, which is the first stage of insulin resistance [16] .
Higher values in insulin sensitivity are related to physical activities subjects, this is evidenced by insulin sensitivity among DB3 subjects. They show statistical higher insulin sensitivity on all methods than DB1 and higher insulin sensitivity values on proposed methods than DB2. This suggests that marathoners' glucose-insulin system works more efficiently than other groups, because they use less insulin to maintain normal glucose levels than sedentary and metabolic syndrome subjects. 
CONCLUSION AND FUTURE WORKS
This work presents the design of an index with insulin sensitivity estimation capabilities by the use of lipidanthropometric variables. To achieve this, a simple correspondence analysis was performed. The nature of relations between insulin-glucose and lipid-anthropometric variables were stated by scatter plots and least square regressions lines. Once it designed, the index was parametrically optimized with an indirect insulin sensitivity method called CAUMO, which is a high accuracy indirect method from a simplification of MINMOD-IGTT.
Results suggest that WC, triglycerides and BMI impaired values, are related to DB1, which is the group with metabolic syndrome and insulin resistance. Thus the new index conformation with these parameters discriminates between normal and insulin resistance subjects. On the other hand, the optimization of proposed index improves the correlation with CAUMO, even more; it surpasses the correlation of the HOMA-IR among DB2 and DB3groups. This suggests that proposed optimized index is more accurate than HOMA-IR, which is the most used method in general practice to insulin resistance diagnosis.
The results also imply the optimized propose index could detect incipient insulin resistance. In early stages of insulin resistance can be detected alterations in postprandial insulin and glucose values. HOMA-IR usually generate a false negative in subjects where the insulin resistance is not reflect in fasting glucose and insulin values, which may led to delay diagnosis and treatment of this pathology. In scatter plot of normalized proposed indexes; LAI-OPT could classify as insulin resistant subjects that present impaired postprandial insulin and glucose values and normal fasting insulin and glucose values.
Proposed index suggests the possibility of an insulin sensitivity indicator among different populations taking simple and minimal invasive parameters (triglycerides, WC and BMI). Further work in large populations is still required to refine the index, because the number of subjects in this study was relatively small. Next work will focus in elderly population. 
